Clinical trial
A Novel Nasal Treatment for COVID-19
NCT05799521 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Novel Nasal Treatment for COVID-19
- Lead sponsor
- Indiana University
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- June 27, 2023
- Completion date
- March 30, 2027
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, healthy